NCT01907503

Brief Summary

To assess the prognostic value of a characteristic evaluation of gait in persons suffering from hip OA for subsequent indications for THR.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
5.5 years until next milestone

First Submitted

Initial submission to the registry

July 17, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 25, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Last Updated

July 25, 2013

Status Verified

July 1, 2013

Enrollment Period

5.8 years

First QC Date

July 17, 2013

Last Update Submit

July 24, 2013

Conditions

Primary Hip Osteoarthritis

Outcome Measures

Primary Outcomes (1)

  • locomotor activity

    participants will be followed for the duration of hospital stay, an expected average of 2 weeks

Study Arms (2)

Patients with Primary hip osteoarthritis

OTHER

Patients with Primary hip osteoarthritis

Procedure: Evaluation of the balance of force platform

Healthy volunteer

OTHER

Healthy volunteer

Procedure: Evaluation of the balance of force platform

Interventions

Evaluation of the balance of force platformPROCEDURE
Healthy volunteerPatients with Primary hip osteoarthritis

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men or women aged between 45 and 75 years Suffering from primary hip osteoarthritis defined according to ACR criteria who presented pain in the hip for at least one month in the preceding 3 months Radiological stage II, III or IV hip OA according to the Kellgren and Lawrence classification Patients able to understand simple instructions des packaging instructions, to give their written informed consent.

You may not qualify if:

  • Spine disease causing gait disturbance (radiculalgia, lumbar canal stenosis,… with, in the opinion of the patient, disability due to this other disease that is greater than the disability caused by the hip OA.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Dijon

Dijon, 21079, France

RECRUITING

Related Publications (2)

  • Yang Q, Ji X, Zhang Y, Du S, Ji B, Zeng W. An interpretable machine learning approach for predicting and grading hip osteoarthritis using gait analysis. BMC Musculoskelet Disord. 2025 Jul 1;26(1):580. doi: 10.1186/s12891-025-08911-6.

    PMID: 40597862DERIVED

  • Moissenet F, Naaim A, Ornetti P, Bourredjem A, Binquet C, Morisset C, Gouteron A, Maillefert JF, Laroche D. Is the Pelvis-Thorax Coordination a Valuable Outcome Instrument to Assess Patients With Hip Osteoarthritis? Front Bioeng Biotechnol. 2020 Jan 23;7:457. doi: 10.3389/fbioe.2019.00457. eCollection 2019.

    PMID: 32039174DERIVED

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2013

First Posted

July 25, 2013

Study Start

February 1, 2008

Primary Completion

December 1, 2013

Last Updated

July 25, 2013

Record last verified: 2013-07

Locations

FR(1)